Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-20 Sale |
2021-07-22 9:01 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
17,400 | $33.14 | $576,575 | 325,103 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-19 9:02 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
4,600 | $33.37 | $153,502 | 278,762 (Direct) |
View |
| 2021-01-14 Sale(A) |
2021-07-19 9:02 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $43.99 | $2,419,344 | 436,330 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-16 9:03 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $32.02 | $960,600 | 835,809 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-07 9:01 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
7,810 | $40.04 | $312,712 | 1,775,684 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 9:00 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
37,489 | $40.05 | $1,501,288 | 1,783,494 (Direct) |
View |
| 2021-06-15 Sale |
2021-06-16 9:47 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $34.1 | $1,022,906 | 865,809 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-19 6:35 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $30.63 | $918,783 | 895,809 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 9:07 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $33.54 | $1,006,106 | 886,524 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 5:58 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $36.32 | $1,089,537 | 916,524 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-11 11:50 am |
Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello 10% Owner |
5,249 | $45 | $236,205 | 5,141,321 (Direct) |
View |
| 2021-01-26 Sale |
2021-01-28 5:08 pm |
Replimune Group Inc. | REPL | Rhodes Jason P Director |
5,558 | $46.14 | $256,446 | 3,228,912 (Indirect) |
View |
| 2021-01-26 Sale |
2021-01-28 09:27 am |
Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner |
30,350 | $45.42 | $1,378,444 | 5,283,682 (Direct) |
View |
| 2021-01-22 Sale |
2021-01-26 9:00 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
60,000 | $44.43 | $2,665,973 | 1,744,118 (Direct) |
View |
| 2021-01-22 Sale |
2021-01-26 09:56 am |
Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner |
11,359 | $45.04 | $511,658 | 5,314,032 (Direct) |
View |
| 2021-01-14 Sale |
2021-01-19 9:53 pm |
Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer |
50,000 | $43.76 | $2,187,790 | 1,255,297 (Direct) |
View |
| 2021-01-14 Sale |
2021-01-19 9:50 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $43.99 | $2,419,344 | 436,330 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-19 9:47 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $43.24 | $1,297,065 | 946,524 (Direct) |
View |
| 2021-01-14 Sale |
2021-01-19 3:02 pm |
Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner |
19,580 | $45.1 | $883,054 | 5,325,391 (Direct) |
View |
| 2021-01-13 Sale |
2021-01-15 9:01 pm |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
15,000 | $44.53 | $667,884 | 294,900 (Direct) |
View |
| 2020-12-22 Sale |
2020-12-28 9:03 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
220,000 | $40.04 | $8,808,800 | 1,804,118 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-20 Exercise |
2021-07-22 9:01 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
17,400 | $0 | 325,103 (Direct) |
View |
| 2021-07-20 Exercise |
2021-07-22 9:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
17,400 | $1.01 | 325,103 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 9:02 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
4,600 | $0 | 278,762 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 9:02 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
4,600 | $1.01 | 278,762 (Direct) |
View |
| 2021-01-14 Exercise(A) |
2021-07-19 9:02 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $0 | 436,330 (Direct) |
View |
| 2021-01-14 Exercise(A) |
2021-07-19 9:02 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $1.01 | 436,330 (Direct) |
View |
| 2021-05-10 Option Award |
2021-05-11 9:01 pm |
N/A 2031-05-10 |
Replimune Group Inc. | REPL | Lewis Tanya Chief Dev. Oper. Off. |
183,333 | $0 | 183,333 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 9:02 pm |
N/A 2031-05-03 |
Replimune Group Inc. | REPL | Patel Sushil Chief Commercial Officer |
213,333 | $0 | 213,333 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:20 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
85,415 | $0 | 261,409 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:19 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Pirzkall Andrea Chief Medical Officer |
51,250 | $0 | 52,250 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:19 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
115,085 | $0 | 115,085 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:18 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
192,165 | $0 | 1,936,283 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:17 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer |
213,540 | $0 | 1,468,837 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:17 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
98,210 | $0 | 984,734 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:16 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Rhodes Jason P Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:15 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Levitsky Hyam Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:14 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Lewis Tanya Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:14 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Pucci Paolo Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:13 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Weinand Dieter Director |
24,750 | $0 | 24,750 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:12 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Slootweg Hugo Alexander Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:11 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:11 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 1:35 pm |
N/A N/A |
Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Paster Anne-Mari Director 10% Owner |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 9:50 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $0 | 436,330 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-19 9:50 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
55,000 | $1.01 | 436,330 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 9:01 pm |
N/A 2029-12-09 |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
15,000 | $0 | 294,900 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 9:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
15,000 | $14.08 | 294,900 (Direct) |
View |
| 2020-12-23 Exercise |
2020-12-28 9:01 pm |
N/A 2026-03-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
50,704 | $0 | 208,752 (Direct) |
View |
| 2020-12-23 Exercise |
2020-12-28 9:01 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
50,704 | $1.75 | 208,752 (Direct) |
View |